Submissions to FDA from EyePoint Pharmaceuticals, Inc. regarding the 02/2024 Inspection

Any submission to FDA from EyePoint Pharmaceuticals, Inc. discussing the FDA observations during the February 2024 inspection of EyePoint Pharmaceuticals, Inc. of 480 Pleasant St, Suite B300, Watertown, MA 02472 (FEI Number 3005508657), including any response(s) to:

(a) the Form FDA 483 issued at the end of the February 2024 inspection of EyePoint Pharmaceuticals, Inc.,

(b) the Establishment Inspection Report associated with the February 2024 inspection of EyePoint Pharmaceuticals, Inc. of 480 Pleasant St, Suite B300, Watertown, MA 02472 (FEI Number 3005508657), and

(c) the Warning Letter issued by FDA to EyePoint Pharmaceuticals, Inc. on July 12, 2024 (MARCS-CMS 679747)